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STUDIES ON BIOLOGICAL FACTORS IN ACANTHOLYSIS*
FILLMORE K. BAGATELL, PH.D., M.D.
Recent interest in the biochemical mecha-
nism of acantholysis has been spurred by
Lever's (1) monograph in which he reported
acantholysis to be diagnostic of pemphigus
vulgaris. Acantholysis can be experimentally
induced in human skin in a variety of ways.
Stoughton (2) observed that fecal filtrates from
patients with ulcerative colitis were capable of
inducing acantholysis in formalin fixed sections
of human skin. It has also been shown that
acantholytic reactions in human skin can be
induced in vitro by 3 to 6M urea, 75%
lithium bromide, mild thermal damage, disulfide
splitting agents and borate buffer above pH
8.5 (3, 4, 5).
Some known enzymes are able to produce
acantholysis in human skin epidermis. Elastase
and papaiu will produce acantholysis in vitro
in fresh human skin (6). Burbach (7) was able
to induce vesieation in skin in vitro and in vivo
with trypsin. Miller and Stoughton (8) found
that papain would induce spongiosis, dermal-
epidermal separation and finally acantholysis
in vivo with increases in the concentration of
papain injected into the dermis.
One of the most interesting agents used to
induce acantholysis is cantharidin. The material
has been known for over 2000 years to be as-
sociated with blister beetles. Dixon at al (9)
have listed 42 species of beetles which are
known sources of cantharidin. Most agents
which induce histologic and macroscopic changes
of vesieation in vivo will fail to do so in vitro.
However, cantharidin will provoke classical
acantholysis in vitro which makes a good model
to study the mechanisms involved in acantholy-
sis.
Burbaeh (10) and Weakley and Einbinder
(11) have recently made maj or contributions
to our knowledge of the mechanism of canthari-
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din aeantholysis. They showed that cantharidin
induced acantholysis will not take place unless
oxygen is present. Burbach inhibited cantharidin
aeantholysis by previous exposure of the skin
to dinitrophenol. Weakley showed that 0.1M
malonie acid and 0.1M glucose will inhibit
eantharidin acantholysis. Stoughton and Baga-
tell (6) noted that pre-treatmeut of skin by
freezing, acetone, alcohol or formalin destroys
the acantholytie potential of eantharidin. Epi-
dermis scraped free from the dermis would not
undergo acantholysis (6).
In this communication, we wish to present
data which indicates that eantharidin induces
or activates a factor (5) in skin which causes
aeantholysis.
MATEEIAL5 AND METHODS
Fresh human skin slices obtained from surgery
were used up to twenty hours after obtaining the
specimen. Skin from four to six day old neo-natal
rats was also used. The skin was washed with dis-
tilled water and blotted dry. Cantharidin powder
was applied to the epidermal surface and the skin
was placed in a humid Petri dish. The Petri dish
was incubated 6 to 16 hours at 37° C. The excess
eantharidin was removed under running cold tap
water. After mincing, the skin tissue was homoge-
nized with ten volumes of 0.OSM Tris (hydroxy-
methyl) amiuomethane (Tris) buffer pH 7.4 in a
pulsating homogenizer designed by Dr. Frank
Voeci of the Edgewood Arsenal, Maryland. The
homogenate was centrifuged at 1000 >< g and 20,000
)< g in a Lourdes refrigerated centrifuge. The final
centrifugatiou at 105,000 X g was performed in a
Spineo Model L ultraeentrifuge. The final super-
natant solution was dialyzed twice in the cold
room VS 50 volumes 0.OO1M Tris buffer pH 7.4.
The dialyzed material was applied in the cold to
a diethylaminoethanol cellulose (DEAE) column.
The protein was eluted with increasing concentra-
tions of Tris buffer pH 7.4 commencing with
0.OO1M and then 0.O1M, 0.05M and 0.1M solutions.
Acidification of the solutions to be tested was per-
formed by adding sufficient concentrated hydro-
chloric acid to reduce the pH to 1.0. After one hour
in an ice bath the solution was returned to pH 7.4
by addition of 6N KOH.
To determine acantholytie activity, fresh human
skin was cut into 2Omm° pieces with a razor blade.
0.1 to 0.3 ml of the aqueous solution to be tested
was injected into the corium with a 26 gauge nee-
dle. The skin was bathed in 3 ml of the test solu-
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tion and incubated at 37° C for 12 to 16 hours.
Appropriate controls were incubated at all times.
The ability of certain reagents noted in a pre-
vious study (6) to inhibit aeantholysis was tested
in the following manner: Concentrated reagent was
added to the supernatant solution containing the
acantholytie factor(s) to make the final desired
concentration. Test skin pieces were added to de-
termine the ability of the reagent to inhibit aean-
tholysis. In other instances 0.1 ml to 05 ml of the
reagent at the test concentration was inj ected into
the curium and this skin was then immersed in the
active supernatant solution. We also tested the in-
hibitory reagents when present in the 105,000Xg
supernatant solution and in the pre-treated skin
slice.
Tritiated cantharidin was obtained from the
Yolk Radiochemical Company. It was produced by
"an aqueous exchange" method. The material ob-
tained was contaminated with non-cantharidin ma-
terial. The product was purified by repeated sub-
limation and recrystallization from acid solution.
The material as used melted at 216° uncorrected
as determined in a Fisher-Johns block. Stork et ol
(12) report the melting point of their synthesized
eantharidin as 212—213°. The purified tritiated can-
tharidin was capable of causing aeantholysis in
euro.
To determine the degree of exchange of the
tritiated cantharidin, the following procedure was
used. 4 mg of the tritiated material was dissolved
in 60 ml of 02M Tris buffer pH 7.6. For five sue-
cesive days, 10 ml aliquots were removed from the
flask and transferred to an ether extraction thim-
ble. The aqueous material was extracted with ether
continuously for 48 hours. The radioactive material
in the ether phase was considered as cantharidin.
The radioactive material not extractable by ether
was considered as tritium which had exchanged
with the hydrogen atoms of the water.
The ether extractable material was evaporated
to dryness. The material was taken up in 10 ml of
0.O1N NaOH and 0.5 ml aliquots were taken for
counting in a Packard Triearb scintillation counter.
The ether insoluble residue was evaporated to 10
ml under a gentle air stream and 0.5 ml aliquots
were taken for counting. The liquid scintillation
material contained per liter: 400 ml toluene, 600
ml absolute ethanol, 50 g naphthalene, 7 g 2,4-
diphenyloxazole and 50 mg 1, 4-bis-2-(phenyloxa-
zolyl)-benzene.
Common reagents as used were of standard ana-
lytical grade. Cantharidin was purchased from In-
land Alkaloid Company. Selectaeel DEAE was
purchased from the Brown Company.
RESULTS
Using Tris buffer as the homogenizing fluid,
we obtained and tested the supernatant solu-
tion obtained after centrifugation at 1000 x
g and 20,000 X g. No acantholytie activity was
found. When the 20,000 >< g supernatant solu-
FIG. 1. Fresh human skin incubated with can-
tharidin at 37° C for six hours (N 250).
tion was centrifuged at 105,000 x g for 60 min-
utes, the supernatant solution induced aeanthol-
ysis in fresh human or baby rat skin. Preparing
extracts in the identical manner from eanthari-
din treated frozen skin did not produce a
solution with acantholytie activity. Figure 1
shows human skin treated topically with can-
tharidin. Figure 2 shows human and rat skin
which underwent aeantholysis after treatment
with a dialyzed 105,000 x g supernatant solu-
tion, derived from eantharidin treated fresh
rat skin.
We have determined some of the properties
of the crude active aeantholytie solution. The
activity is stable to dialysis against Tris buf-
fer, but not against distilled water. The ma-
terial resists rapid freezing and thawing, but
is not stable upon lyophilization and reconsti-
tution. It is stable to heating at 100° C for 2
minutes, but not at 100° C for 10 minutes. On
standing at 5° C for two weeks there is loss
of activity. Acidification and neutralization of
the active 105,000 >< g supernatant solution
results in loss of activity.
A very interesting observation was the ability
of the insoluble material obtained at 20,000 x g
and 105,000 >< g to inhibit the aeantholytie
factor(s) when added back to the supernate.
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FIG. 2. (A) Fresh human skin treated with a dialyzed 105,000 X g supernatant solution derived from
eantharidin-treated neo-natal rat skin (X 250). (B) Fresh adult rat skin treated as in (A) (X 250).(C) Fresh neo-natal rat skin treated as in (B) (X 250).
This is probably the reason for our initial
failure to detect this activity in low speed
supernatant solutions. Crude yeast RNA at a
level of 2 mg/ml will also inhibit the active
acantholytic supernatant solution.
Attempts at fractionation of the crude super-
natant material have been made. We have
fciund that the active acantholytic factor can
be removed by elution from DEAE cellulose
with Tris buffer 0.OSM pH 7.4. However, about
50% of the protein initially applied to the
column is removed with such an active frac-
tion. When we have used such standard methods
of protein fractionation such as ammonium sul-
fate, ethanol, calcium phosphate gel, alumina C7
gel and hydroxyapaptite columns the fractions
obtained do not have acantholytic activity.
Stoughton and Bagatell (6) found several
reagents which would inhibit the ability of
topically applied cantharidin to induce acanthol-
ysis. We have tested some of these reagents
for their ability to inhibit the activity of the
active, high-speed, supernatant solution to cause
acantholysis. The data are shown in Table I.
It is seen that hydroeortisone acetate, medrol
succinate and AgNO3 do not inhibit the soluble
acantholytic factor(s). The CuSO4 is of in-
terest in that it inhibits the soluble factor(s)
when in the same solution, but apparently
not when present only in the skin itself.
The use of cantharidin to induce acantho-
lytic factor(s) in skin extracts presented a
serious problem. To our knowledge, there is
not an adequate method available for the esti-
mation of the quantity of cantharidin present
in biological fluid or in tissues. Selenous acid can
be used for the micro-estimation of the pure
compound, but cannot be used directly in
biological fluids or with ether or chloroform
extracts (13). We wished to ascertain whether
any residual cantharidin was present in our
active dialyzed supernatant solution obtained
after centrifugation at 105,000 >< g. Epstein and
Kligman (14) found that as little as lOfig per
ml of cantharidin could induce acantholysis in
human skin. We were able to solve this problem
by the use of eantharidin containing tritium
applied topically to human skin. Table II records
the data obtained in our experiment. It is seen
that up to 13.5 percent of the total topically
applied cpm are present in the high-speed
supernatant solutions. 6 mg of labeled canthari-
din was dissolved in 0.4 ml of Tris buffer and
applied to 10 gm of human skin slices. The
specific activity of the tritiated cantharidin
was 33,446 cpm/mg. The apparent cantharidin
concentration of the non-dialyzed supernatant
solution did not satisfy the criterion of having
less than l0tg per ml present in solution. The
active dialyzed material contained O.O7fig per
ml of cantharidin which is insufficient canthari-
din to produce acantholysis.
We were concerned about the tritium atoms
of eantharidin exchanging with hydrogen atoms
of the aqueous medium. We attempt to esti-
mate the rate of exchange by extracting the
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DISCUSSION
= mean
TABLE III
Rate of exchange of cantharidin
labeled with tritium
tritium labeled purified eantharidin with ether
for 48 hours. The radioactivity associated with
the ether extractable material was assumed to
be tritium which had not exchanged. The radio-
activity associated with the material not ether
extractable was assumed to be exchanged tritium.
The results arc presented in Table III. It is
seen that between days three and four, or the
time required to prepare the skin homogenate
and dialyze same, 68 percent of the tritium
had exchanged with the aqueous medium.
The data obtained in this experiment indicates
that the cpm shown in Table II for the fractions
TABLE I
Effect of some reagents upon the acantholylic activity
of 105,000 X supernatant solution
nay
Total Counts
per Minute
Extractable
by Ether5
Total Counts
per Minute
Not Extrac- Excbange
table by Etbert
I
II
III
IV
V
13,596
7,652
4,640
3,946
3,456
116
6,538
9,746
10,470
11,630
0.73
40.4
68.2
73.0
81.5
* Tritium labeled cantharidin.
t Exchanged tritium.
t Exchanged tritium/14,258. 14,258
total cpm.
before dialysis are contributed by cantharidin
itself. The supernatant and residue fraction were
all prepared on day I. The 105,000 x g superna-
tant solution which was dialyzed for two days
has 68 percent more cantharidin present than
indicated in the column "apparent cantharidin
concentration". In spite of the exchange, it is
clear that there is an insufficient amount of
cantharidin present in the dialyzed supcrnatant
solution to cause acantholysis.
Reagent Concen-tration
Reagen
to-jetted
snto
Dermis
Reagent
Preoent
Only in
Super-
natant
——————
Reagent
Present
in
Dermis
and
Super-
nataest
Hydrocortisone ace- 1/250
tate
Medrol suceinate 1/500
CuSO4 1/500
HgCI2 1/500
AgNo3 1/500
As20, 1/10,000
N-ethylmaleimide 1/10,000
+
+
+
0
+
0
0
+
+
0
0
+
0
0
+
+
0
0
+
0
0
TABLE II
Application of tritiated cantharidin* to
human skin slices
Fraction Coer volume
Minute (ml)
Apparent
baridin
Cant-
Concen-
tration
(pg/mI)
Total cpm eanthari-
din-T applied
20,000g supernatant so-
lution
20,000g residue
105,000gsupernatantso-
lution
105,000g residue
105,000g supernatant so-
lution after dialysis
First 50 volumes Tris
buffer 0.05M p117.4
Second 50 volumes Tris
buffer 0.05M p117.4
200,676
27,000
119
22,140
84
98
26,000
0
60
45
40
2000
2000
10.5
11.7
0.07
We believe that this work supports the con-
cept that cantharidin releases acantholytic fac-
tor(s) in skin. Weakely (15) has suggested that
"soluble cantharidin extracts a thermostable
acantholytic factor from unfixed mouse liver,
spleen and skin". We have shown that canthari-
din induces an acantholytic factor in fresh
human or nco-natal intact skin, which is de-
tected only in the supernatant solution re-
sulting from centrifugation at 105,000 X g. It
would appear that the residue obtained after
centrifugation binds the acantholytic factor(s)
OF contains an inhibiting compound.
The acantholytic factor(s) seems to be as-
sociated with protein and displays properties
suggestive of an enzyme. The activity is lost
on standing at 5° C for two weeks. Compounds
such as As203, Hg and N-ethylmaleidide de-
stroy activity as does acidification. Attempts at
maintaining acantholytic activity during pro-
tein purification have been relatively unsuc-
cessful.
We have used cantharidin containing tritium
to induce an acantholytic reaction. Our data
indicates that 13 percent of applied counts* Specific activity = 33,446 cpm/mg.
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are present in the high-speed supernatant solu-
tion, hut practically all counts are lost upon
dialysis. The fact that 68 per cent of the tritium
exchanges with the aqueous medium does not
affect the concept that cantharidin was effec-
tively removed by dialysis. The concentration
of cantharidin present in the dialyzed material
was one hundredth of the minimal effective con-
centration of cantharidin necessary to produce
acantholysis.
The relationship of the acantholytic factor(s)
induced by cantharidin to known biochemical
actions remains obscure at present. Decker (16)
has shown that both oxidation and phosphoryl-
ation in aged mitochondria isolated from rat
livers utilizing glutamate or succinate are inhib-
ited by cantharidin. In our laboratory, we
have found that oxidative phosphorylation is
uncoupled in the case of substrates such as sue-
cinate or beta-hydroxybutyrate. However, glu-
tamate and alpha-keto glutarate utilization is
stimulated utilizing fresh rat liver mitoehondria.
We have also found that cantharidin is a potent
mitoehondrial swelling agent, but does not form
lipoperoxides. One link between the two research
areas is the inhibition of the acantholytie factor
and stimulation of glutamate utilization by
crude yeast RNA and the particulate matter ob-
tained after centrifugation at 105,000 x g. We
have found that yeast RNA purified by the
method of Crestfield et al (17) does not in-
hibit the cantharidin induced stimulation. There
may be a minor constituent of the crude material
that is the inhibitor factor. We are currently in-
vestigating this problem.
At present, our working hypothesis is that the
cantharidin acts to disrupt lipoprotein mem-
branes. Once inside the cell the compound
can act to disrupt the lipoprotein membranes
of such structures as the mitochondrion and also
to induce in cutaneous tissue factors(s) capable
of causing aeantholysis.
SUMMARY AND CONCLUSIONS
1. Acantholytic factor(s) are produced in
fresh skin tissue after treatment with canthari-
din. The active factor(s) are detected only in
the supernatant solution resulting from cen-
trifugation at 105,000 >< g.
2. The aeantholytic factor(s) seem to be as-
sociated with protein. Acidification, heating at
1000 C for 10 minutes and loss of activity on
standing at 5 C for two weeks are some of the
properties of the factor(s).
3. Cantharidin containing tritium was used
to estimate the amount of the vesicant in the
active supcrnatant fluid. It was found that the
concentration of cantharidin present in the
dialyzed material was one hundredth of the
minimal effective concentration necessary to pro-
duce acantholysis.
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